SUPPLEMENT

Q4 2023 — Income statement trends

Q4 2023PDF · 2 pages143 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q421 	Q122 	Q222 	Q322 	Q422 	Q123 	Q223 	Q323 	Q423
Revenues:
Clearing and transaction fees 	949.3 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5
Market data and information services 	142.1 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6 	167.2
Other Revenue 	55.9 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7 	87.6
Total revenues 	1,147.3 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3
Expenses:
Compensation and benefits 	201.7 	185.2 	185.3 	189.6 	193.0 	204.5 	205.7 	205.5 	212.9
Technology 	45.8 	45.9 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6 	58.5
Professional fees and outside services 	32.3 	31.8 	32.0 	35.1 	38.5 	38.3 	37.8 	32.2 	36.1
Amortization of purchased intangibles 	58.6 	58.4 	57.1 	55.5 	56.7 	56.8 	57.0 	57.2 	55.6
Depreciation and amortization 	35.9 	33.5 	33.0 	34.5 	33.9 	31.9 	32.3 	31.1 	30.7
Licensing and other fee agreements 	60.4 	80.9 	83.1 	83.6 	72.4 	84.7 	78.2 	79.5 	80.4
Other expense 	80.9 	51.8 	51.1 	43.9 	95.0 	60.4 	57.3 	56.5 	101.9
Operating expenses 	515.6 	487.5 	487.5 	489.0 	539.5 	527.9 	521.6 	517.6 	576.1
Operating Income 	631.7 	859.1 	749.7 	738.8 	668.3 	913.7 	838.6 	820.2 	863.2
Operating Margin 	55% 	64% 	61% 	60% 	55% 	63% 	62% 	61% 	60%
Non-operating Income and Expense
Investment income 	67.8 	73.1 	286.9 	686.2 	1,152.2 	1,357.7 	1,568.2 	1,272.5 	1,076.9
Interest and other borrowing costs 	(41.9) 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7)
Equity in net gains (losses) of unconsolidated subsidiaries 	67.5 	73.3 	87.3 	76.5 	64.0 	78.2 	75.1 	76.8 	66.8
Other non-operating income (expense) 	74.2 	(46.7) 	(217.3) 	(581.1) 	(1,017.3) 	(1,152.8) 	(1,425.3) 	(1,155.6) 	(961.2)
Non-operating income (expense) 	167.6 	57.2 	117.0 	141.2 	159.0 	243.2 	177.8 	154.1 	142.8
Income before income taxes 	799.3 	916.3 	866.7 	880.0 	827.3 	1,156.9 	1,016.4 	974.3 	1,006.0
Income taxes 	174.1 	205.3 	204.2 	200.4 	189.4 	273.1 	238.8 	224.1 	191.4
Net income 	625.2 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2 	814.6
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	625.2 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2 	814.6
Net Income Attributable to Common Shareholders of CME Group 	613.3 	702.0 	654.1 	671.1 	629.9 	872.7 	767.8 	740.8 	804.3
Effective Tax Rate 	21.8% 	22.4% 	23.6% 	22.8% 	22.8% 	23.6% 	23.5% 	23.0% 	19.0%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.71 	1.96 	1.82 	1.87 	1.76 	2.43 	2.14 	2.06 	2.24
Diluted EPS 	1.71 	1.95 	1.82 	1.87 	1.75 	2.43 	2.14 	2.06 	2.24
Weighted average number of common stock shares:
Basic Shares 	358,582 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020 	359,197
Diluted Shares 	359,019 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619 	359,693
Preferred Shares 	2,890 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q421 	Q122 	Q222 	Q322 	Q422 	Q123 	Q223 	Q323 	Q423
Revenues:
Clearing and transaction fees 	949.3 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5
Market data and information services 	142.1 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6 	167.2
Other Revenue 	55.9 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7 	87.6
Total revenues 	1,147.3 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3
Expenses:
Compensation and benefits 	183.7 	182.8 	189.5 	189.1 	184.6 	192.8 	194.4 	193.5 	204.4
Technology 	45.6 	45.8 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6 	58.5
Professional fees and outside services 	27.2 	30.3 	31.4 	35.1 	38.5 	38.3 	37.8 	32.2 	36.1
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	35.6 	33.5 	32.9 	33.8 	33.9 	31.9 	31.8 	31.1 	29.8
Licensing and other fee agreements 	60.4 	80.9 	83.1 	81.9 	72.4 	84.7 	78.2 	79.5 	80.4
Other expense 	76.5 	51.7 	59.6 	54.4 	84.5 	59.7 	56.2 	56.5 	80.3
Operating expenses 	429.0 	425.0 	442.4 	441.1 	463.9 	458.7 	451.7 	448.4 	489.5
Operating Income 	718.3 	921.6 	794.8 	786.7 	743.9 	982.9 	908.5 	889.4 	949.8
Operating Margin 	63% 	68% 	64% 	64% 	62% 	68% 	67% 	66% 	66%
Non-operating Income and Expense
Investment income 	58.2 	74.7 	299.5 	688.5 	1,147.1 	1,277.5 	1,564.0 	1,276.6 	1,068.5
Interest and other borrowing costs 	(41.9) 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7)
Equity in net gains (losses) of unconsolidated subsidiaries 	78.7 	84.7 	98.2 	89.6 	76.2 	91.5 	88.6 	90.4 	85.1
Other non-operating income (expense) 	(33.0) 	(43.4) 	(218.5) 	(585.7) 	(1,023.3) 	(1,160.6) 	(1,429.9) 	(1,157.1) 	(958.8)
Non-operating income (expense) 	62.0 	73.5 	139.3 	152.0 	160.1 	168.5 	182.5 	170.3 	155.1
Income before income taxes 	780.3 	995.1 	934.1 	938.7 	904.0 	1,151.4 	1,091.0 	1,059.7 	1,104.9
Income taxes 	172.8 	228.9 	217.6 	219.6 	206.0 	269.1 	254.6 	241.7 	240.2
Net income 	607.5 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0 	864.7
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	607.5 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0 	864.7
Net Income Attributable to Common Shareholders of CME Group 	595.7 	756.6 	707.5 	710.0 	689.1 	871.1 	825.9 	807.9 	853.8
Effective Tax Rate 	22.1% 	23.0% 	23.3% 	23.4% 	22.8% 	23.4% 	23.3% 	22.8% 	21.7%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.66 	2.11 	1.97 	1.98 	1.92 	2.43 	2.30 	2.25 	2.38
Diluted EPS 	1.66 	2.11 	1.97 	1.98 	1.92 	2.42 	2.30 	2.25 	2.37
Weighted average number of common stock shares:
Basic Shares 	358,582 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020 	359,197
Diluted Shares 	359,019 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619 	359,693
Preferred Shares 	2,890 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --